Carregant...
Galectin‐3 as a candidate upstream biomarker for quantifying risks of myocardial ageing
AIMS: Galectin‐3 (Gal‐3) is implicated in the pathogenesis of heart failure and is also influenced by ageing. This study aims to determine the extent to which Gal‐3 levels estimate odds of myocardial dysfunction in ageing cohorts, ‘upstream’ prior to clinical disease. METHODS AND RESULTS: Four hundr...
Guardat en:
| Publicat a: | ESC Heart Fail |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816233/ https://ncbi.nlm.nih.gov/pubmed/31392851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12495 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|